Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

By                

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1707-1714

Spandidos Publications

Access to resources Recommend Favorite

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

By Bertucci François  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 363-373

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Early Breast Cancer: Optimal and Suboptimal Anthracycline-Containing Regimens

By Cocconi G.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 313-320

Springer Publishing Company

Access to resources Recommend Favorite

Economic Analyses of Toxicity Secondary to Anthracycline-based Breast Cancer Chemotherapy

By Dranitsaris G.   Tran T.M.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2174-2180

Elsevier

Access to resources Recommend Favorite

Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy - a phase I, dose-finding study

By Lortholary A.   Maillard P.   Delva R.   Boisdron-Celle M.   Perard D.   Vernillet L.   Besenval M.   Gamelin E.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1773-1780

Elsevier

Access to resources Recommend Favorite